Clinical Report: Correction on Stem-like CD4 T Cells in Tumors
Background
Understanding the role of stem-like CD4 T cells in tumors is crucial for advancing cancer immunotherapy. Accurate information regarding research affiliations is essential for maintaining the integrity of scientific communication.
Data Highlights
No numerical or trial data is presented in the correction article.
Key Findings
The authors' correct affiliation is the Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
The original article discussed the emerging framework for antitumor immunity related to stem-like CD4 T cells.
Related studies emphasize the importance of established immune biomarkers in cancer immunotherapy.
Recent research has clarified the interaction between stem-like T-cell states and antitumor immunity.
Current guidelines do not include stem-like CD4 T-cell measurements as essential biomarkers for clinical decision-making.
Clinical Implications
The correction of authorship affiliation underscores the importance of accurate representation in scientific literature. Clinicians should remain informed about the evolving landscape of biomarkers in immunotherapy.
Conclusion
This correction highlights the need for precise institutional affiliations in research publications, which is vital for the credibility of scientific discourse.
